244 related articles for article (PubMed ID: 10732655)
1. Prior benzodiazepine use and buspirone response in the treatment of generalized anxiety disorder.
DeMartinis N; Rynn M; Rickels K; Mandos L
J Clin Psychiatry; 2000 Feb; 61(2):91-4. PubMed ID: 10732655
[TBL] [Abstract][Full Text] [Related]
2. Imipramine and buspirone in treatment of patients with generalized anxiety disorder who are discontinuing long-term benzodiazepine therapy.
Rickels K; DeMartinis N; García-España F; Greenblatt DJ; Mandos LA; Rynn M
Am J Psychiatry; 2000 Dec; 157(12):1973-9. PubMed ID: 11097963
[TBL] [Abstract][Full Text] [Related]
3. Switching from benzodiazepines to buspirone using a tapered overlap method in generalized anxiety disorder.
Arató M
J Clin Psychiatry; 2001 Aug; 62(8):657-8. PubMed ID: 11561943
[No Abstract] [Full Text] [Related]
4. Abecarnil for the treatment of generalized anxiety disorder: a placebo-controlled comparison of two dosage ranges of abecarnil and buspirone.
Pollack MH; Worthington JJ; Manfro GG; Otto MW; Zucker BG
J Clin Psychiatry; 1997; 58 Suppl 11():19-23. PubMed ID: 9363044
[TBL] [Abstract][Full Text] [Related]
5. Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder.
Davidson JR; DuPont RL; Hedges D; Haskins JT
J Clin Psychiatry; 1999 Aug; 60(8):528-35. PubMed ID: 10485635
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy and withdrawal of clobazam, lorazepam and buspirone in the treatment of anxiety disorders].
Lemoine P; Rouillon F; Pouget D
Encephale; 1996; 22(6):461-7. PubMed ID: 10901839
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the efficacy of buspirone in patients affected by generalized anxiety disorder, shifting to buspirone from prior treatment with lorazepam: a placebo-controlled, double-blind study.
Delle Chiaie R; Pancheri P; Casacchia M; Stratta P; Kotzalidis GD; Zibellini M
J Clin Psychopharmacol; 1995 Feb; 15(1):12-9. PubMed ID: 7714222
[TBL] [Abstract][Full Text] [Related]
8. A multicentre double-blind comparison of hydroxyzine, buspirone and placebo in patients with generalized anxiety disorder.
Lader M; Scotto JC
Psychopharmacology (Berl); 1998 Oct; 139(4):402-6. PubMed ID: 9809861
[TBL] [Abstract][Full Text] [Related]
9. Treatment of generalized anxiety disorder: preliminary clinical experience with buspirone.
Petracca A; Nisita C; McNair D; Melis G; Guerani G; Cassano GB
J Clin Psychiatry; 1990 Sep; 51 Suppl():31-9. PubMed ID: 2211564
[TBL] [Abstract][Full Text] [Related]
10. Buspirone and lorazepam in the treatment of generalized anxiety disorder in outpatients.
Laakmann G; Schüle C; Lorkowski G; Baghai T; Kuhn K; Ehrentraut S
Psychopharmacology (Berl); 1998 Apr; 136(4):357-66. PubMed ID: 9600581
[TBL] [Abstract][Full Text] [Related]
11. Buspirone in the long-term treatment of generalized anxiety disorder.
Feighner JP
J Clin Psychiatry; 1987 Dec; 48 Suppl():3-6. PubMed ID: 3320034
[TBL] [Abstract][Full Text] [Related]
12. Buspirone: multicenter efficacy study.
Wheatley D
J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):92-4. PubMed ID: 6130079
[TBL] [Abstract][Full Text] [Related]
13. Low-sedation potential of buspirone compared with alprazolam and lorazepam in the treatment of anxious patients: a double-blind study.
Cohn JB; Wilcox CS
J Clin Psychiatry; 1986 Aug; 47(8):409-12. PubMed ID: 2874128
[TBL] [Abstract][Full Text] [Related]
14. Panic disorder and response to sertraline: the effect of previous treatment with benzodiazepines.
Rapaport MH; Pollack MH; Clary CM; Mardekian J; Wolkow R
J Clin Psychopharmacol; 2001 Feb; 21(1):104-7. PubMed ID: 11199932
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of buspirone in generalized anxiety disorder with coexisting mild depressive symptoms.
Sramek JJ; Tansman M; Suri A; Hornig-Rohan M; Amsterdam JD; Stahl SM; Weisler RH; Cutler NR
J Clin Psychiatry; 1996 Jul; 57(7):287-91. PubMed ID: 8666569
[TBL] [Abstract][Full Text] [Related]
16. Comparison of buspirone and diazepam in generalized anxiety disorder.
Jacobson AF; Dominguez RA; Goldstein BJ; Steinbook RM
Pharmacotherapy; 1985; 5(5):290-6. PubMed ID: 2866493
[TBL] [Abstract][Full Text] [Related]
17. A double-blind comparison of buspirone, clobazam, and placebo in patients with anxiety treated in a general practice setting.
Böhm C; Placchi M; Stallone F; Gammans RE; Alms DR; Shrotriya RC; Robinson DS
J Clin Psychopharmacol; 1990 Jun; 10(3 Suppl):38S-42S. PubMed ID: 1973939
[TBL] [Abstract][Full Text] [Related]
18. Prior benzodiazepine exposure and benzodiazepine treatment outcome.
Rickels K; Freeman EW
J Clin Psychiatry; 2000 Jun; 61(6):409-13. PubMed ID: 10901337
[TBL] [Abstract][Full Text] [Related]
19. Comparison of withdrawal of buspirone and diazepam: a placebo controlled study.
Fontaine R; Beaudry P; Beauclair L; Chouinard G
Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(2-3):189-97. PubMed ID: 2888159
[TBL] [Abstract][Full Text] [Related]
20. Hydroxyzine for generalised anxiety disorder.
Guaiana G; Barbui C; Cipriani A
Cochrane Database Syst Rev; 2010 Dec; (12):CD006815. PubMed ID: 21154375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
